UNSPSC 85762237: Supplement chest wall with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement chest wall with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WU847Z

UNSPSC 85762237, Supplement chest wall with autologous tissue substitute, percutaneous endoscopic approach (Commodity), does not align with recent state and local procurement activity. The code's nominal scope describes a specific surgical procedure involving autologous tissue grafting, but the recent opportunities posted under this code span occupational medical surveillance, independent medical evaluations for disability benefits, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-outs for employee health plans, and emergency medical services for detained youth. None of these activities involve the tissue-grafting procedure the code nominally describes. The mismatch suggests either a data-entry error in the source material or a misalignment between code assignment and actual procurement scope.

The geographic spread of the six opportunities spans Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State (Washington Department of Transportation), Florida (Collier County), and Texas (Harris County). Response dates cluster in the September-October 2026 window, with most deadlines falling between September 25 and October 16, 2026. The issuing bodies are mixed across city and county health systems, county commissioners' offices, and state departments, reflecting administrative rather than clinical procurement patterns.